Gilead Sciences competitors

View the competitive landscape for Gilead, featuring companies like AstraZeneca, Lilly, and Biogen. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Company icon
Gilead Sciences (Gilead)

Biopharmaceutical company focused on virology, oncology and inflammation

gilead.com

List of Gilead Sciences (Gilead) competitors

  • Company icon

    AstraZeneca

    Science-led biopharmaceutical company

    astrazeneca.com
  • Company icon

    Eli Lilly and Company (Lilly)

    Global biopharmaceutical company

    lilly.com
  • Company icon

    Biogen

    Biopharmaceutical company for neurological, immune, and rare diseases

    biogen.com
  • Company icon

    Novartis

    Innovative medicines company

    novartis.com
  • Company icon

    MSD

    Research-intensive biopharmaceutical company

    msd.com
  • Company icon

    Bristol Myers Squibb (BMS)

    Global biopharmaceutical company

    bms.com
  • Company icon

    GSK

    Global biopharmaceutical company

    gsk.com
  • Company icon

    Sanofi

    R&D-driven, AI-powered biopharmaceutical company

    sanofi.com
  • Company icon

    AbbVie

    Biopharmaceutical company

    abbvie.com
  • Company icon

    Amgen

    Multinational biopharmaceutical company

    amgen.com
  • Company icon

    Johnson & Johnson

    Diversified healthcare company developing treatments for infectious and inflammatory diseases

    jnj.com
  • Company icon

    Merck

    Research-intensive biopharmaceutical company

    merck.com
  • Company icon

    Pfizer

    Biopharmaceutical company

    pfizer.com
  • Company icon

    Regeneron

    Biopharmaceutical company

    regeneron.com
  • Company icon

    Roche

    Healthcare company specializing in pharmaceuticals and diagnostics for oncology

    roche.com
  • Company icon

    ViiV Healthcare

    Specialist company focused exclusively on HIV treatments and research

    viivhealthcare.com
Track Gilead & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.